Line 6: | Line 6: | ||
<style> | <style> | ||
− | + | .foto-grande { | |
− | . | + | |
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
background: url(https://static.igem.org/mediawiki/2017/6/68/Aqaunesp-main-header.png) no-repeat center center; | background: url(https://static.igem.org/mediawiki/2017/6/68/Aqaunesp-main-header.png) no-repeat center center; | ||
width: 100%; | width: 100%; | ||
Line 27: | Line 15: | ||
-moz-background-size: cover; | -moz-background-size: cover; | ||
-o-background-size: cover; | -o-background-size: cover; | ||
− | } | + | } |
@font-face { | @font-face { | ||
Line 41: | Line 29: | ||
− | <div class=" | + | <div class="foto-grande" style="background: url(https://static.igem.org/mediawiki/2017/6/68/Aqaunesp-main-header.png)"> |
<div class="insubiota-text">INSUBIOTA</div> | <div class="insubiota-text">INSUBIOTA</div> |
Revision as of 13:35, 1 November 2017
iGEM AQA_Unesp
INSUBIOTA
treating diabetes with genetically engineered probiotic